Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001832406-24-000003
Filing Date
2024-03-28
Accepted
2024-03-28 16:14:42
Documents
1
Period of Report
2024-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1711656866.html 4/A  
1 FORM 4/A wk-form4a_1711656866.xml 4/A 3860
  Complete submission text file 0001832406-24-000003.txt   5283
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Leffler Scott J. (Reporting) CIK: 0001832406 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26642 | Film No.: 24799114